Substance P

DB19198InvestigationalProtein Based Therapies

Substance P is under investigation in clinical trial NCT03738878 (Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1).

Also known as
Arg-pro-lys-pro-gln-gln-phe-phe-gly-leu-met-nh2 · Methioninamide, l-arginyl-l-prolyl-l-lysyl-l-prolyl-l-glutaminyl-l-glutaminyl-l-phenylalanyl-l-phenylalanylglycyl-l-leucyl- · Neurokinin p · Neuropeptide sp-1 · Sh-oligopeptide-73
Code names
AS-77493 · Q411041

Resolves to

Compound
UNII675VGV5J1DCAS33507-63-0
Targets
P25103TACR1

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
11Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Substance P, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In